Kelly Blackburn
Direttore Tecnico/Scientifico/R&S presso CERVOMED INC.
Patrimonio netto: 341 713 $ in data 30/04/2024
Profilo
Kelly Blackburn is currently the Chief Executive Officer & Director at Bach Pharma, Inc. and the Senior Vice President-Clinical Development at CervoMed, Inc. Prior to these roles, Blackburn was the Vice President-Clinical Affairs at aTyr Pharma, Inc. from 2013 to 2016.
Blackburn received an undergraduate degree from the University of New Hampshire, a graduate degree from Quinnipiac College, Inc., and a graduate degree from Cambridge College Lima SRL.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CERVOMED INC.
0.17% | 26/01/2024 | 13 674 ( 0.17% ) | 341 713 $ | 30/04/2024 |
Posizioni attive di Kelly Blackburn
| Società | Posizione | Inizio |
|---|---|---|
| CERVOMED INC. | Direttore Tecnico/Scientifico/R&S | 16/08/2023 |
Bach Pharma, Inc.
 Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bach Pharma, Inc. is a private company dedicated to developing new therapeutics for the treatment of life-threatening neurodegenerative diseases. The company is based in North Andover, MA. Recently, the company has been encouraged by the effects of GVT on COVID-19 and a recent study found the effectiveness of GVT in Gulf War illness. Bach Pharma's GVT has also been featured in a Texas A&M publication. Kelly Blackburn has been the CEO of the company since 2016. | Amministratore Delegato | 15/07/2016 |
Precedenti posizioni note di Kelly Blackburn
| Società | Posizione | Fine |
|---|---|---|
| ATYR PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2016 |
Formazione di Kelly Blackburn
| University of New Hampshire | Undergraduate Degree |
| Quinnipiac College, Inc. | Graduate Degree |
| Cambridge College Lima SRL | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| CERVOMED INC. | Commercial Services |
| Aziende private | 1 |
|---|---|
Bach Pharma, Inc.
Bach Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bach Pharma, Inc. is a private company dedicated to developing new therapeutics for the treatment of life-threatening neurodegenerative diseases. The company is based in North Andover, MA. Recently, the company has been encouraged by the effects of GVT on COVID-19 and a recent study found the effectiveness of GVT in Gulf War illness. Bach Pharma's GVT has also been featured in a Texas A&M publication. Kelly Blackburn has been the CEO of the company since 2016. | Health Technology |
- Borsa valori
- Insiders
- Kelly Blackburn
